Skip to main content
Log in

WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma

  • Original Article - Tumor - Meningioma
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Background

Meningiomas may show a different WHO grade and variable biological and clinical behaviors. The aim of the present study is to assess whether WHO grade, proliferation index, progesterone receptor (PR) expression, histological subtype, neuroradiological features, and the recurrence rate differ depending on the tumor location.

Methods

Three hundred meningiomas operated on from 2006 to 2016 were reviewed. The WHO grade (2007 classification), Ki67-MIB1, progesterone receptor expression, and histological subtype were reexamined and correlated to the meningioma location, classified as medial skull base, lateral skull base, non-skull base, and spinal.

Results

Non-skull base and lateral skull base meningiomas showed significantly higher rates of atypical WHO II forms (34% and 25.5% respectively) than medial skull base (12.5%) and spinal ones (7%) (p = 0.0003) and also higher rates of tumors with Ki67-Li > 4% (42% and 38% vs 22% and 14%) (p = 0.0031). The rate of meningiomas with PR expression ≤ 50% was significantly lower in medial skull base (25%) than in non-skull base (48%) (p = 0.009). Meningothelial and transitional meningiomas were more frequent at the skull base (68.5% and 54.5%, respectively), the fibroblastic subtype at the non-skull base (48.5%), and the psammomatous at the spinal canal (50%) (p < 0.00001). Medial skull base and spinal meningiomas showed significantly lower size (p < 0.00001), lower rates of cases with lost arachnoid interface (p = 0.0022), and significantly lower recurrence rates (p = 0.0035) than lateral skull base and non-skull base meningiomas.

Conclusion

Medial skull base meningiomas show lower size, lower rate of atypical forms, lower Ki67-Li values, and significantly higher PR expression than those at the lateral skull base and non-skull base. This corresponds to lesser aggressiveness and lower recurrence rates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Albdezahar E, El-Gendi SM, Yehya A, Gowil AG (2011) Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression. Br J Neurosurg 25:707–713

    Google Scholar 

  2. Barresi V, Alafaci C, Caffo M, Barresi G, Tuccari G (2012) Clinicopathological characteristics, hormone receptor status and matrix metallo-proteinase-9 (MMP-9) immunohistochemical expression in spinal meningiomas. Pathol Res Pract 208:350–355

    CAS  PubMed  Google Scholar 

  3. Batarfi M, Valasek P, Krejci E, Huang R, Patel K (2017) The development and origins of vertebrate meninges. Bio Comm 62:73–81

    Google Scholar 

  4. Bhat AR, Wani MA, Kirmani AR, Ramzan AU (2014) Histological subtypes and anatomical location correlated in meningeal brain tumors (meningiomas). J Neurosci Rural Pract 5:244–249

    PubMed  PubMed Central  Google Scholar 

  5. Catala M (1998) Embryonic and fetal development of structures associated with the cerebro-spinal fluid in man and other species. Part I: The ventricular system, meninges and choroid plexuses. Arch Anat Cytol Pathol 46:153–169

    CAS  PubMed  Google Scholar 

  6. Claus EB, Park PJ, Carroll R, Chan J, Black PM (2008) Specific genes expressed in association with progesterone receptors in meningioma. Cancer Res 68:314–322

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Cornelius JF, Slotty PJ, Steiger HJ, Hänggi D, Polivka M, George B (2013) Malignant potential of skull base meningioma s versus non-skull base meningioma’s: clinical series of 1.663 cases. Acta Neurochir 155:407–413

    PubMed  Google Scholar 

  8. Giombini S, Solero CL, Lasio G, Morello G (1984) Immediate and late outcome of operations for parasagittal and falx meningiomas: report of 342 cases. Surg Neurol 21:427–435

    CAS  PubMed  Google Scholar 

  9. Hale AT, Wang L, Strother MK, Chambless LB (2018) Differentiating meningioma grade by imaging features on magnetic resonance imaging. J Clin Neurosci 48:71–75

    PubMed  Google Scholar 

  10. Hashimoto N, Rabo CS, Okita Y, Kinoshita M, Kagawa N, Fujimoto Y et al (2012) Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies. J Neurosurg 116:574–580

    PubMed  Google Scholar 

  11. Hwang WL, Marsicano AB, Niemierko A et al (2016) Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade. Neuro-Oncology 18:863–872

    PubMed  Google Scholar 

  12. Ildan F, Erman T, Gocer AI et al (2007) Predicting the probability of meningioma recurrence in the preoperative and early postoperative period; a multivariate analysis in the midterm follow-up. Skull Base 17:157–171

    PubMed  PubMed Central  Google Scholar 

  13. Jiang X, Iseki S, Maxson RE, Sucov HM, Morriss-Kay GM (2002) Tissue origins and interactions in the mammalian skull vault. Dev Biol 241:106–116

    CAS  PubMed  Google Scholar 

  14. Kalamarides M, Stemmer-Rachamimov AO, Niwa-Kawakita M, Chareyre F, Taranchon E, Han ZY et al (2011) Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes. Oncogene 30:2333–2344

    CAS  PubMed  Google Scholar 

  15. Kane AJ, Sughrue ME, Rutkowski MJ, Shangari G, Fang S, Mcdermott MW et al (2011) Anatomic location is a risk factor for atypical and malignant meningiomas. Cancer 117:1272–1278

    PubMed  Google Scholar 

  16. Kasuya H, Kubo O, Tanaka M, Amano K, Kato K, Hori T (2006) Clinical and radiological features related to the growth potential of meningiomas. Neurosurg Rev 29:293–296

    PubMed  PubMed Central  Google Scholar 

  17. Klekamp J, Samii M (1999) Surgical results for spinal meningiomas. Surg Neurol 52:552–562

    CAS  PubMed  Google Scholar 

  18. Koutourousiou M, Fernandez-Miranda JC, Stefko ST, Wang EW, Snyderman CH, Gardner PA (2014) Endoscopic endonasal surgery for suprasellar meningiomas: experience with 75 patients. J Neurosurg 120:1326–1339

    PubMed  Google Scholar 

  19. Kuroi Y, Matsumoto K, Shibuya M, Kasuya H (2018) Progesterone receptor is responsible for benign biology of skull base meningioma. World Neurosurg 118:e918–e924

    PubMed  Google Scholar 

  20. Lam Shin Cheung V, Kim A, Sahgal A, Das S (2018) Meningioma recurrence rates following treatment: a systematic analysis. J Neuro-Oncol 136:351–361

    Google Scholar 

  21. Lee JH, Sade B, Choi E, Golubic M, Prayson R (2006) Meningothelioma as the predominant histological subtype of midline skull base and spinal meningioma. J Neurosurg 105:60–64

    PubMed  Google Scholar 

  22. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109

    PubMed  PubMed Central  Google Scholar 

  23. Magill ST, Young JS, Chae R, Aghi MK, Theodosopoulos PV, McDermott MW (2018) Relationship between tumor location, size, and WHO grade in meningioma. Neurosurg Focus 44:E4

    PubMed  Google Scholar 

  24. Maiti TK, Bir SC, Patra DP, Kalakoti P, Guthikonda B, Nanda A (2016) Spinal meningiomas: clinicoradiological factors predicting recurrence and functional outcome. Neurosurg Focus 41(2):E6

    PubMed  Google Scholar 

  25. Maiuri F, Del Basso De Caro ML, de Divitiis O, Guadagno E, Mariniello G. (2019) Recurrence of spinal meningiomas: analysis of the risk factors. Br J Neurosurg

  26. Maiuri F, Del Basso De Caro ML, Esposito F, Cappabianca P, Strazzullo V, Pettinato G et al (2007) Recurrences of meningioma: predictive value of pathological features and hormonal and growth factors. J Neuro-Oncol 82:63–68

    Google Scholar 

  27. Maiuri F, Iaconetta G, de Divitiis O, Cirillo S, Di Salle F, De Caro ML (1999) Intracranial meningiomas: correlations between MR imaging and histology. Eur J Radiol 31(1):69–75

    CAS  PubMed  Google Scholar 

  28. Mansouri A, Klironomos G, Taslimi S, Kilian A, Gentili F et al (2016) Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas. J Neurosurg 125:431–440

    PubMed  Google Scholar 

  29. Mariniello G, Maiuri F, Strianese D, Donzelli R, Iuliano A, Tranfa F et al (2008) Spheno-orbital meningiomas: surgical approaches and outcome according to the intraorbital extent. Zentralbl Neurochir 69:175–181

    CAS  PubMed  Google Scholar 

  30. Maroon JC, Kennerdell JS, Vidovich DV, Abla A, Sternau L (1994) Recurrent spheno-orbital meningioma. J Neurosurg 80:202–208

    CAS  PubMed  Google Scholar 

  31. McGovern SL, Aldape KD, Munsell MF, Mahajan A, DeMonte F, Woo SY (2010) A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas. J Neurosurg 112:925–933

    PubMed  Google Scholar 

  32. Meling TR, Da Broi M, Scheie D, Helseth E (2019) Meningiomas: skull base versus non-skull base. Neurosurg Rev 42:163–173

    PubMed  Google Scholar 

  33. Metellus P, Nanni I, Dussert C, Trinkhaus M, Fuentes S, Chinot O et al (2008) Prognostic implications of biologic markers in intracranial meningiomas: 120 cases. Neurochirurgie 54:750–756

    CAS  PubMed  Google Scholar 

  34. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL (1985) Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62:18–24

    CAS  PubMed  Google Scholar 

  35. Nakamura M, Tsuji O, Fujiyoshi K, Hosogane N, Watanabe K, Tsuji T et al (2012) Long-term surgical outcomes of spinal meningiomas. Spine (Phila Pa 1976) 37:E617–E623

    Google Scholar 

  36. Nakasu S, Fukami T, Jito J, Nozaki K (2009) Recurrence and regrowth of benign meningiomas. Brain Tumor Pathol 26:69–72

    PubMed  Google Scholar 

  37. Nakasu S, Nakasu Y, Nakajima M, Matsuda M, Handa J (1999) Preoperative identification of meningiomas that are highly likely to recur. J Neurosurg 90:455–462

    CAS  PubMed  Google Scholar 

  38. Nanda A, Vannemreddy P (2008) Recurrence and outcome in skull base meningiomas: do they differ from other intracranial meningiomas? Skull Base 18:243–252

    PubMed  PubMed Central  Google Scholar 

  39. O’Rahilly R, Müller F (1986) The meninges in human development. J Neuropathol Exp Neurol 45:588–608

    PubMed  Google Scholar 

  40. Perry A, Gutmann DH, Reifenberger G (2004) Molecular pathogenesis of meningiomas. J Neuro-Oncol 70:183–202

    Google Scholar 

  41. Pravdenkova S, Al-Mefty O, Sawyer J, Husain M (2006) Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas. J Neurosurg 105:163–173

    CAS  PubMed  Google Scholar 

  42. Rohringer M, Sutherland GR, Louw DF, Sima AA (1989) Incidence and clinicopathological features of meningioma. J Neurosurg 71:665–672

    CAS  PubMed  Google Scholar 

  43. Roser F, Nakamura M, Bellinzona M, Ritz R, Ostertag H, Tatagiba MS (2006) Proliferation potential of spinal meningiomas. Eur Spine J 15:211–215

    PubMed  Google Scholar 

  44. Roser F, Nakamura M, Bellinzona M, Rosahl SK, Ostertag H, Samii M (2004) The prognostic value of progesterone receptor status in meningiomas. J Clin Pathol 57:1033–1037

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Roser F, Nakamura M, Ritz R, Bellinzona M, Dietz K, Samii M, Tatagiba MS (2005) Proliferation and progesterone receptor status in benign meningiomas are not age dependent. Cancer 104:598–601

    CAS  PubMed  Google Scholar 

  46. Roser F, Samii M, Ostertag H, Bellinzona M (2004) The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir 146:37–44

    CAS  PubMed  Google Scholar 

  47. Sade B, Chahlavi A, Krishnaney A, Nagel S, Choi E, Lee JH (2007) World Health Organization grades II and III meningiomas are rare in the cranial base and spine. Neurosurgery 61:1194–1198

    PubMed  Google Scholar 

  48. Sandalcioglu IE, Gasser T, Mohr C, Stolke D, Wiedemayer H (2005) Spheno orbital meningiomas: interdisciplinary surgical approach, respectability and long-term results. J Craniomaxillofac Surg 33:260–266

    PubMed  Google Scholar 

  49. Savardekar AR, Patra DP, Bir S, Thakur JD, Mohammed N, Bollam P, Georgescu MM, Nanda A (2018) Differential tumor progression patterns in skull base versus non-skull base meningiomas: a critical analysis from a long-term follow-up study and review of literature. World Neurosurg 112:e74–e83

    PubMed  Google Scholar 

  50. Spektor S, Valarezo J, Fliss DM, Gil Z, Cohen J, Goldman J et al (2005) Olfactory groove meningiomas from neurosurgical and ear, nose, and throat perspectives: approaches, techniques, and outcomes. Neurosurgery 57(4 Suppl):268–280

    PubMed  Google Scholar 

  51. Spille DC, Sporns PB, Heβ K, Stummer W, Brokinkel B (2019) Predict of high-grade histology and recurrence in meningiomas using routine preoperative magnetic resonance imaging: a systematic review. World Neurosurg 128:174–181

    PubMed  Google Scholar 

  52. Standring S, Ellis H, Wigley C (2016) Gray’s anatomy: the anatomical basis of clinical practice. Elsevier Churchill Livingstone, New York

    Google Scholar 

  53. Wolfsberger S, Doostkam S, Boecher-Schwarz HG, Roessler K, van Trotsenburg M, Hainfellner JA et al (2004) Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature. Neurosurg Rev 27:238–245

    PubMed  Google Scholar 

  54. Zhou P, Ma W, Yin S, Li Y, Jiang S (2013) Three risk factors for WHO grade II and III meningiomas: a study of 1737 cases from a single center. Neurol India 61:40–44

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuseppe Mariniello.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

For this retrospective study, no institutional review board approval or patient consent is required per institutional policy.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Tumor - Meningioma

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maiuri, F., Mariniello, G., Guadagno, E. et al. WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma. Acta Neurochir 161, 2553–2561 (2019). https://doi.org/10.1007/s00701-019-04084-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-019-04084-z

Keywords

Navigation